BioNxt Solutions Inc.
BNXT
CNSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 49.56% | -53.04% | |||
| Depreciation & Amortization | -18.37% | 219.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.34% | -38.66% | |||
| Operating Income | -17.31% | 38.66% | |||
| Income Before Tax | -23.90% | 31.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.90% | 31.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.90% | 31.69% | |||
| EBIT | -17.31% | 38.66% | |||
| EBITDA | -17.52% | 38.27% | |||
| EPS Basic | -22.22% | 31.93% | |||
| Normalized Basic EPS | -20.00% | 27.54% | |||
| EPS Diluted | -22.22% | 31.93% | |||
| Normalized Diluted EPS | -20.00% | 27.54% | |||
| Average Basic Shares Outstanding | 1.35% | 0.61% | |||
| Average Diluted Shares Outstanding | 1.35% | 0.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||